ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,759Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 944

$1M Total Retail Price of All Prescriptions

Rank: 17 out of 944

476 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 476 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

19% of this provider’s 476 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 14,903 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
LEVOTHYROXINE SODIUM 786 703 1 2
FUROSEMIDE 686 646 2 6
LISINOPRIL 481 448 3 3
SERTRALINE HCL 430 402 4 23
OMEPRAZOLE 423 369 5 4
CITALOPRAM HBR 406 348 6 19
DONEPEZIL HCL 399 397 7 24
NAMENDA 394 390 8 37
HYDROCODONE-ACETAMINOPHEN 393 286 S3 9 10
MIRTAZAPINE 380 357 10 35
AMLODIPINE BESYLATE 374 362 11 5
GABAPENTIN 332 307 12 18
QUETIAPINE FUMARATE 328 318 13 69
METOPROLOL TARTRATE 326 292 14 8
WARFARIN SODIUM 266 237 15 7
LIDODERM 244 244 16 73
DIVALPROEX SODIUM 239 203 17 85
SIMVASTATIN 233 190 18 1
LANTUS 224 188 19 46
FENTANYL 179 167 S2 20 57
SEROQUEL 171 159 21 142
RISPERIDONE 155 125 22 78
PANTOPRAZOLE SODIUM 153 137 23 34
KLOR-CON M20 151 149 24 71
TRAMADOL HCL 149 143 25 21
CYMBALTA 131 123 26 75
TRAZODONE HCL 128 88 27 45
LAMOTRIGINE 126 67 28 150
IPRATROPIUM-ALBUTEROL 124 123 29 101
CARBAMAZEPINE 112 63 30 164
TAMSULOSIN HCL 112 112 30 27
VENLAFAXINE HCL ER 112 96 30 84
POLYETHYLENE GLYCOL 3350 110 103 33 41
METOLAZONE 110 105 33 133
PAROXETINE HCL 109 89 35 64
LOSARTAN POTASSIUM 103 103 36 16
ATENOLOL 103 96 36 11
OLANZAPINE 102 78 38 125
BACLOFEN 102 75 38 111
CLOPIDOGREL 101 99 40 36
ATORVASTATIN CALCIUM 100 77 41 13
POTASSIUM CHLORIDE 97 94 42 15
CARVEDILOL 96 94 43 30
PLAVIX 94 90 44 55
LEVETIRACETAM 93 54 45 97
DIVALPROEX SODIUM ER 93 79 45 170
CLONIDINE HCL 93 78 45 67
LACTULOSE 92 61 48 161
METOPROLOL SUCCINATE 88 88 49 14
ABILIFY 88 70 49 166
METFORMIN HCL 88 79 49 12
OXYCODONE-ACETAMINOPHEN 86 75 S2 52 62
CARBIDOPA-LEVODOPA 85 85 53 77
OXYCONTIN 83 80 S2 54 92
ESCITALOPRAM OXALATE 82 72 55 98
GLYBURIDE 80 71 R 56 63
AZITHROMYCIN 76 45 57 70
ADVAIR DISKUS 75 71 58 31
LYRICA 72 62 59 114
PREDNISONE 70 67 60 32
LEVOFLOXACIN 70 66 60 117
GLIPIZIDE 70 65 60 51
DIGOXIN 69 67 63 39
DILTIAZEM 24HR CD 68 68 64 124
METHIMAZOLE 66 66 65 264
PHENYTOIN SODIUM EXTENDED 66 52 65 168
TRIAMCINOLONE ACETONIDE 64 63 67 105
NYSTOP 61 55 68 126
ACETAMINOPHEN-CODEINE 60 55 S3 69 95
HUMULIN R 59 57 70 242
NYSTATIN 59 56 70 134
LEXAPRO 57 52 72 229
MELOXICAM 56 41 73 68
ALLOPURINOL 55 54 74 22
NOVOLOG 53 35 75 93
HYDROCORTISONE 52 49 76 217
DIOVAN 51 51 77 38
HYDRALAZINE HCL 50 48 78 87
COMBIVENT 50 49 78 107
EXELON 50 50 78 149
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.